{"schema_version":"secwatch.filing_event.v1","accession":"0001486957-22-000025","form_type":"8-K","ticker":"BWXT","cik":"0001486957","company_name":"BWX Technologies, Inc.","filed_at":"2022-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.892669+00:00","generated_at":"2026-06-24T02:44:06.133586+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BWXT Q2 2022 revenue $554M (+10% YoY), EPS $0.82 (+32%), raises 2022 guidance","bullets":["Revenue $554M (+10% YoY); GAAP EPS $0.82 (+32%); adjusted EBITDA $114.7M (+26%).","Government Operations rev $437M (+8%); Commercial Operations rev $119M (+16%).","Increases 2022 guidance: revenue +6.5-8.0%, adj. EBITDA +5.0-6.5%, non-GAAP EPS $3.08-$3.23.","Completes Tc-99m reference batches for FDA submission; starts first U.S. advanced microreactor for DoD.","Cash from ops $77.4M; dividend $0.22/share payable Sept 8; $398M remaining buyback authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001486957-22-000025","json":"https://secwatch.observer/filing/0001486957-22-000025.json","markdown":"https://secwatch.observer/filing/0001486957-22-000025.md","text":"https://secwatch.observer/filing/0001486957-22-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1486957/000148695722000025/0001486957-22-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1486957/000148695722000025/bwxt-20220808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T02:44:06.133586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}